ARC Therapeutics
Other - , ,
ARC Therapeutics Employees
ARC Therapeutics Senior Management
ARC Therapeutics Details
Incyclix Bio, LLC (previously Arc Therapeutics, LLC) is a next-generation cell cycle control company, advancing precision treatments that target the aberrant proliferation driving many cancers. The company's lead compound is a potent and selective cyclin-dependent kinase 2 (CDK2) inhibitor nearing clinical stage. Incyclix Bio is a scientific leader in understanding cyclin-dependent kinases (CDKs) and their role in the cell cycle as attractive therapeutic targets across many tumor types, including ovarian, breast and lung cancers. Headquartered in Research Triangle Park, NC, Incyclix Bio is founded by pioneers in CDK inhibitor discovery, research and development.
ARC Therapeutics Technologies
Email Providers
Outlook
CMS
WP Engine
Fonts
Typekit
Tag Management
Google Tag Manager
Hosting
Google Cloud Hosting
CSS and JavaScript Libraries
Bootstrap Framework